Your session is about to expire
← Back to Search
Lorundrostat for High Blood Pressure
Study Summary
This trial tests if a new drug can help lower high blood pressure, when taken with other medications.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Media Library
- Your weight and height measurements give you a body mass index (BMI) between 18 and 40.I haven't had cancer in the last 5 years, except for skin cancer or carcinoma in-situ.I am on essential heart/blood pressure medication that cannot be stopped.I have not been in a trial for new treatments or drugs in the last 6 months.I am allergic to certain blood pressure medications.I have not had a heart attack, stroke, or mini-stroke in the last year.The Principal Investigator thinks that you have a condition that will prevent you from participating in the study.I experience sudden dizziness when standing up.You have a current or presumed problem with your autonomic nervous system.You have a history of drug or alcohol abuse within the past year.Your upper arm is larger than 55 centimeters around at the screening visit.You have an allergic reaction to lorundrostat or any of its ingredients.
- Group 1: Placebo
- Group 2: Dose 1
- Group 3: Dose 2
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do the potential benefits of Dose 1 outweigh any possible risks to patients?
"The safety of Dose 1 was rated a 2 on the risk scale, as this is only Phase 2 trial and thus lacks evidence to support efficacy. However, there are some results that suggest it may be safe for general use."
What is the maximum number of participants allowed in this research endeavor?
"Confirmed. Clinicaltrials.gov data attests to this medical research being active, which was first made available on March 1st 2023 and modified most recently on the 3rd of that same month. The trial is looking for 300 participants from just one site."
Are any slots still available for eligible participants in this research endeavor?
"Affirmative. Per the information disseminated on clinicaltrials.gov, this trial is still actively seeking participants. It was initially posted on March 1st 2023 and it's most recent update occurred on March 3rd of that same year. The primary research objective requires 300 patients to be enrolled from a single healthcare facility."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- GenHarp Clinical Solutions: < 48 hours
- Eagle Clinical Research: < 48 hours
- Clinical Research of West Florida: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger